2023-24 Academic Year
Sept. 6
“Pharmacogenomics of Chemotherapeutic-Induced Neurotoxicities”
M. Eileen Dolan, Ph.D.
University of Chicago Medicine Comprehensive Cancer Center
Oct. 18
“Immuno-therapeutic Targeting of AML- Restricted Antigens”
Soheil Meshinchi, M.D., Ph.D.
Fred Hutchinson Cancer Center
Nov. 1
“Cancer Associated Thrombosis, 150 years of progress since Trousseau”
Gerald A. Soff, M.D.
Sylvester Comprehensive Cancer Center
Dec. 6
“Harnessing Pancreas Adenocarcinoma Plasticity for Therapeutic Intent”
Colin D. Weekes, M.D., Ph.D.
Dana-Farber Harvard Cancer Center
Jan. 10
“Management of Locally Advanced Rectal Cancer in 2024”
Deborah Schrag, M.D., M.P.H.
Memorial Sloan Kettering Cancer Center
Jan. 24
“Germline Predisposition to Hematopoietic Malignancies”
Lucy A. Godley, M.D., Ph.D.
Robert H. Lurie Comprehensive Cancer Center
Feb. 21
“Use of Genomics and Other Omics Data to Gain New Insights into Cancer Etiology and Biology”
Wei Zheng, M.D., Ph.D., M.P.H.
Vanderbilt-Ingram Cancer Center
April 17
“Dissecting Heterogeneity of Immune Checkpoint Response”
Joshua Meeks, MD, PhD
Robert H. Lurie Comprehensive Cancer Center
2022-23 Academic Year
Sept. 7
“Breaking Down Pancreatic Cancer”
Jen Jen Yeh, M.D.
University of North Carolina
Sep. 21
“Translational genomics of medulloblastoma: advances in predisposition, stratification, & diagnosis”
Paul A. Northcott, Ph.D.
St. Jude Children’s Research Hospital
Oct. 19
“Latent Viruses and Cancer: Revisiting the Whorfian Hypothesis”
Patrick Moore, M.D., M.P.H.
University of Pittsburgh
Nov. 2
“Engineered T cell Therapy for Pediatric Cancer”
Stephen Gottschalk, M.D.
St. Jude Children’s Research Hospital
Nov. 16
“Nonoperative Management in Rectal Cancer: Waste of Time or Worth the Wait?”
J. Joshua Smith, M.D., Ph.D., FACS
Memorial Sloan Kettering Cancer Center
Nov. 30
“Shared Decision Making around Breast Cancer Screening in Older Women”
Mara A. Schonberg, M.D., M.P.H.
Harvard Medical School
Dec. 14
“Improving skin cancer prevention activities through precision prevention”
Peter Kanetsky, Ph.D., M.P.H.
Moffitt Cancer Center
Jan. 11
“Lung Cancer Screening, Where Are We and Where Are We Going Next?”
Rafael Meza, Ph.D.
University of Michigan
Feb. 8
“Sexuality, Cancer, and the Human Experience: From Acknowledgment to Recovery”
Don S. Dizon, M.D.
The Warren Alpert Medical School of Brown University
Feb. 22
“Cervical Cancer Prevention in the United States: The Promise of Innovations and the Challenges of Real-World Implementation”
Cosette Wheeler, Ph.D.
University of New Mexico
March 8
“Optimizing Patient Centered Care to Improve PROs in Cancer Survivors”
Frank J. Penedo, Ph.D.
Sylvester Comprehensive Cancer Center
March 15
“Ancestry: Inflammation and Drug Discovery”
Sean Kimbro, Ph.D.
Morehouse School of Medicine
March 22
“Current Knowledge and Approaches for Treatment Advances”
Richard Gorlick, M.D.
The University of Texas MD Anderson Cancer Center
March 29
“Multi-Disciplinary Approach to Building Resources to Address the Needs of Colorectal Cancer Patients: Focus on Biobanking and Energy Balance”
Erin Siegel, Ph.D., M.D.
University of South Florida
April 19
“Advances in Renal Cell Carcinoma: Decades of Progress”
Rana R. McKay
University of California San Diego
May 10
“Cracking the Door of Pancreatic Cancer: From Health Disparities to Potential Molecular Targets”
Antonio T. Baines, Ph.D.
UNC-Chapel Hill
2021-22 Academic Year
Sept. 1
“Key Components for Making Impactful Research Advances in Pancreatic Cancer in Florida: A Passionate Transdisciplinary Team, a Shared Vision, and Cutting-Edge Science”
Jennifer B. Permuth, Ph.D., M.S.
H. Lee Moffitt Cancer Center & Research Institute
Sept. 15
“Using Biomarkers to Help Personalize Therapy for Prostate Cancer Patients”
Felix Y. Feng, M.D.
University of California, San Francisco
Sept. 29
“Is post-transplant cyclophosphamide a true game-changer in allogeneic transplantation: The struggle to unlearn”
Richard J. Jones, M.D.
Johns Hopkins University
Oct. 13
“Advances in The Management of Hepatocellular Carcinoma”
Richard S. Finn, M.D.
University of California Los Angeles
Oct. 27
“Using Multi-Omics and AI to Accelerate Precision Medicine”
Olivier Elemento, Ph.D.
Weill Cornell Medicine
Dec. 1
UF Health Cancer Center Town Hall Meeting: “The Road to NCI Designation: An Update”
Jonathan D. Licht, M.D.
UF Health Cancer Center
Jan. 12
“From AI Analyses to LGBT Cancer Disparities: Population Sciences in the 21st Century”
Matthew B. Schabath, Ph.D.
H. Lee Moffitt Cancer Center & Research Institute
Jan. 26
“Multidimensional Mayhem: EWS/FLI in Ewing Sarcoma”
Stephen L. Lessnick, M.D., Ph.D.
Nationwide Children’s Hospital
Feb. 23
“A Multi-Level Model to Address Cervical Cancer Disparities in Appalachia”
Electra Paskett, Ph.D.
The Ohio State University College of Medicine
March 30
“Financial Toxicity and Cancer in America”
Fumiko Chino, M.D.
Memorial Sloan Kettering Cancer Center
April 13
“Overcoming Metastatic Spread of Osteosarcoma with RNA-Loaded Nanoparticles”
John Ligon, M.D.
University of Florida
April 27
“Prostate Cancer Diagnosis: The Past, Present and Future of Systematic Biopsy”
Wayne G. Brisbane, M.D.
University of Florida
May 4
“Natural Experiments in Health Care”
Anupam B. Jena, M.D., Ph.D.
Harvard Medical School
May 11
“Immuno-Oncology Target in Patients with African Ancestry”
Clayton C. Yates, Ph.D.
Tuskegee University
May 25
“Should social relationships be considered a vital sign in cancer patients and what can be done to help socially isolated patients?”
Candyce Kroenke, M.P.H., Sc.D.
Kaiser Permanente Northern California Division of Research
2020-21 Academic Year
SEPT. 16
“The role of minimally invasive surgery in ovarian cancer”
Joel Cardenas, M.D.
University of Florida
Sept. 23
“Prognostic radiology: Imaging insights into tumor pathophysiology and optimizing therapy response”
Ralph Mason, Ph.D.
UT Southwestern Medical Center
Oct. 7
“The Myriad Machinations of Myelodysplastic Syndromes”
Mikkael Sekeres, M.D., M.S.
Cleveland Clinic Taussig Cancer Institute
Oct. 14
“Breast Cancer Related Lymphedema: Overcoming the Challenge”
Lisa R. Spiguel, M.D.
University of Florida
Oct. 21
“Advances in the management of hormone sensitive breast cancer”
William Gradishar, M.D
Northwestern University
Oct. 28
“Glioblastoma Immunotherapy: Hitting the Gas and Avoiding the Brakes”
David A. Reardon, M.D.
Dana-Farber Cancer Institute
Nov. 4
“Update on Cellular Therapies”
Jack W. Hsu, M.D.
University of Florida
Nov. 18
“The role of the gut and tumor microbiome in cancer”
Jennifer Wargo, M.D., MMSc
The University of Texas MD Anderson Cancer Center
Dec. 2
“HER2 positive metastatic breast cancer: Integrating the Drug Tsunami”
Sandra M. Swain, M.D.
Georgetown University
Dec. 16
“Technology-based innovations in incentive interventions to promote smoking cessation”
Jesse Dallery, Ph.D.
University of Florida
Jan. 6
“Smoking Cessation as the Fourth Pillar of Cancer Care: Lessons from the NCI’s Moonshot Cancer Center Cessation Initiative (C31) Program”
Michael Fiore, M.D., M.P.H., M.B.A. University of Wisconsin-Madison
Jan. 13
“A proteogenomic analysis of breast cancer”
Matthew J. Ellis, M.D., BChir, BSc., Ph.D., FRCP
Baylor College of Medicine
Jan. 20
“Epigenetics in aging, cancer and cancer therapy”
Jean-Pierre Issa, M.D.
Coriell Institute for Medical Research
Jan. 29
“From Team Science to Consortia Science: A Global Framework for Addressing Cancer Disparities”
Folakemi T. Odedina, Ph.D.
University of Florida
Feb. 3
“NRG Oncology: Case Study of a National Research Group”
Walter J. Curran, Jr., M.D., FACR, FASCO
Emory University
Feb. 10
“Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer”
Paul Crispen, M.D.
University of Florida
Feb. 17
“Targeting RNA: protein interactions in acute leukemia”
Iannis Aifantis, Ph.D.
New York University
Feb. 24
“Nanomedicines for the Research, Detection, and Treatment of Cancer and Allied Diseases”
Daniel A. Heller, Ph.D.
Memorial Sloan Kettering Cancer Center
March 3
“Eco-Oncology”
Brent Reynolds, Ph.D.
University of Florida
March 10
“New Directions in Cancer Control and Population Sciences”
Robert A. Hiatt, M.D., Ph.D.
University of California San Francisco
March 17
“Systematic Approach in Cancer Chemoprevention”
Nagi B. Kumar, Ph.D., R.D., FADA
H. Lee Moffitt Cancer Center & Research Institute
April 7
“Organoids to model human disease”
Hans Clevers, Ph.D.
University Utrecht
April 14
“Radiosensitizers: 2021 update”
Kathryn E. Hitchcock, M.D., Ph.D. University of Florida
April 21
“Epidemiology of Head and Neck Cancer: Opportunities and Challenges”
Andrew F. Olshan, Ph.D.
University of North Carolina at Chapel Hill
April 28
“Role of papillomaviruses in human cancers and their evasion of host immune responses”
Paul Lambert, Ph.D.
University of Wisconsin-Madison
May 5
“Cachexia and the Tumor Macroenvironment in Pancreatic Cancer”
Teresa A. Zimmers, Ph.D.
Indiana University
May 12
“Reprogramming the immunosuppressive tumor microenvironment in head and neck cancer with personalized RNA nano-vaccines”
Natalie L. Silver, M.D., M.S.
University of Florida
May 19
“Personalized medicine in the era of cancer genomics and immunology”
Christine Chung, M.D.
H. Lee Moffitt Cancer Center & Research Institute
2019-20 Academic Year
Sept. 11
“Proton Therapy: Promise and Proof”
Nancy P. Mendenhall, M.D., FASTRO
University of Florida
Sept. 18
“Promising New Approaches for Relapsed/Refractory Non-Hodgkin Lymphoma”
Nancy L. Bartlett, M.D.
Washington University
Sept. 25
“Yoga for the Treatment of Toxicities and Side Effects Among Cancer Patients”
Karen M. Mustian, Ph.D., M.P.H.
University of Rochester
Oct. 2
“Understanding human cancer Tregs and targeting Tregs for cancer immunotherapy”
Weizhou Zhang, Ph.D.
University of Florida
Oct. 16
“Cancer Metastasis: Issues and Challenges”
Dietmar Siemann, Ph.D.
University of Florida
Oct. 23
“Molecular Imaging Now! Nearinfrared Fluorescence in Biliary and Hepatic Surgery”
Ali Zarrinpar, M.D., Ph.D.
University of Florida
Nov. 6
“Bone Targeted Therapies in Breast Cancer”
Katherine N. Weilbaecher, M.D.
Washington University
Nov. 13
“The Cancer Imaging Archive as an Example of Semantic Data Integration”
Mathias Brochhausen, Ph.D.
University of Florida
Dec. 4
“Biopsychosocial Contributions to Pain: Implications for Cancer Survivors”
Roger Fillingim, Ph.D.
University of Florida
Dec. 11
“Personalized treatment strategies to improve the outcome for high-risk pediatric acute lymphoblastic leukemia”
Richard B. Lock, Ph.D., FAHMS
Children’s Cancer Institute, Australia
Jan. 8
“The Day We Achieved Equity in Cancer Care”
Christina Chapman, M.D., M.S.
University of Michigan
JAN. 15
“Cancer Nanomedicine”
Carlos Rinaldi, Ph.D.
University of Florida
Jan. 22
“Nursing Homes and Cancer”
Allen Goodman, Ph.D.
Wayne State University
Jan. 29
“Targeting the tumor immune microenvironment (TIME) of HPV-related cancers”
Andrew Sikora, M.D., Ph.D.
Baylor College of Medicine
Feb. 5
“CDC’s Role in Cancer Control”
Lisa C. Richardson, M.D., M.P.H.
Centers for Disease Control and Prevention
Feb. 12
“De-Intensification of Treatment for Oropharynx Cancer”
Robert J. Amdur, M.D.
University of Florida
Feb. 19
“An orientation to implementation science at the National Cancer Institute and opportunities for advancing the field”
Gila Neta, Ph.D., MPP
National Cancer Institute
FEb. 26
“Understanding Outcome Disparities in Head and Neck Cancer”
Kevin Cullen, M.D.
University of Maryland
March 11
“Using implementation science strategies to decrease HPV-related cancers”
Stephanie Staras, Ph.D.
University of Florida
APRIL 8
“Assessing Implementation Costs in the NCI’s Cancer Center Cessation Initiative”
Ramzi Salloum, Ph.D.
University of Florida
April 17
“Rational Combinations of Immunotherapy for Glioblastoma”
Robert M. Prins, Ph.D.
University of California, Los Angeles
April 22
“Recent Advances in Neoadjuvant Chemotherapy for Breast Cancer”
Terry P. Mamounas, M.D.
UF Health Cancer Center – Orlando Health
May 6
“From worst prognosis to best diagnosis: How targeted therapy has changed the natural history of HER2-driven breast cancer and how the field is continuing to evolve”
Sara A. Hurvitz, M.D.
University of California, Los Angeles
May 13
“Testing and Implementing Tobacco Prevention and Cessation Programs for Adolescents: The Power of Social Connections and Interactivity”
Georges Khalil, Ph.D.
University of Florida
MAY 20
“Immunotherapy against brain cancer”
Catherine Flores, Ph.D.
University of Florida
2018-19 Academic Year
Sept. 12
“Quantifying Myocardial Dysfunction after Radiation Therapy in Breast Cancer Patients”
Walter O’Dell, Ph.D.
University of Florida
Oct. 3
“Sex After Cancer”
Kathleen Green, M.D.
University of Florida
Oct. 24
“Precision epigenetic-immunotherapy therapy for B-cell lymphomas”
Ari M. Melnick, M.D.
Weill Cornell Medicine
NoV. 7
UF Health Cancer Center Town Hall Meeting
Jonathan D. Licht, M.D.
Director, UF Health Cancer Center
Nov. 28
“Targeted Therapy of Leukemia”
John C. Byrd, M.D.
The Ohio State Unversity Comprehensive Cancer Center
Dec. 5
“The Centrality of Family Communication to Cancer Coping and Risk Reduction in Familial and Clinical Settings: Mothers, Daughters & Breast Cancer”
Carla L. Fisher, Ph.D.
University of Florida
Dec. 12
“Epigenetic Therapies”
Peter Jones, Ph.D., DSc
Van Andel Research Institute
Jan. 9
“Chinese herbal medicine as modulators of chemotherapy for the treatment of metastatic colorectal cancer”
Edward Chu, M.D.
University of Pittsburgh
Jan. 16
“Multi-Omics approaches to advance personalized therapy in AML”
Jatinder Lamba, Ph.D., M.Sc,
University of Florida
Jan. 23
“Moving Modern Systemic Therapy for Advanced Non-small Cell Lung Cancer into Earlier Stages”
Nathan Pennell, M.D., Ph.D.
The Cleveland Clinic
Jan. 30
“Improving Cancer Care and Outcomes: A Healthcare Delivery Research Agenda”
Paul Jacobsen, Ph.D.
National Cancer Institute
Feb. 6
“Breast Cancer Precision Medicine: Targeting HER2 Activating Mutations”
Ron Bose, M.D., Ph.D.
Washington University
Feb. 20
“Cancer and Aging: Implications for Cancer Survivors’ Experiences”
Patricia Ganz, M.D.
Jonsson Comprehensive Cancer Center, UCLA Fielding School of Public Health
March 20
“The 3q26 Amplicon: A Multi-genic Driver of Transformation”
Verline Justilien, Ph.D.
Mayo Clinic
April 3
“Genomics of Acute Myeloid Leukemia”
John S. Welch, M.D., Ph.D.
Washington University
May 1
“Addressing patient, provider and systems-level barriers for delivery of tobacco treatment in cancer care”
Jamie S. Ostroff, Ph.D.
Memorial Sloan Kettering Cancer Center
May 8
“Using electronic health records data for cancer-related population research”
Celette Skinner, Ph.D.
UT Southwestern Medical Center
2017-18 Academic Year
May 16
“Pancreas Cancer: Lessons Learned Through Our Slow Progress”
Jordan Berlin, M.D.
Vanderbilt-Ingram Cancer Center
May 2
“Activating NKcells for Cancer Immunotherapy”
Todd Fehniger, M.D., Ph.D.
Washington University School of Medicine
